2007: Vasculitis I

Vasculitis I

1226

Is Really [18FDG] Pet-Scan a Reliable Way to Assess Disease Activity in Takayasu’s Arteritis ?

1227

Procalcitonin at the Onset of Giant Cell Arteritis and Polymyalgia Rheumatica : The GRACG Prospective Study

1228

Fdg-Pet in the Large-Vessel Vasculitis: Role in Assessing the Disease Activity

1229

The Role of ¹⁸FDG PET/CT Scanning in Assessing Flares and Disease Activity in Patients with Takayasu’s Arteritis

1230

Human Temporal Artery Culture on Matrigel: A Useful Method for Preclinical Assessment of Functional Changes after Intervention

1231

-463 G/a Myloperoxidase Promoter Polymorphism in Giant Cell Arteritis

1232

Colchicine: Randomized Double-Blind Controlled Crossover Study in Behcet’s Disease

1233

Evaluation and Revision of the International Study Group Criteria for Behçet’s Disease

1234

Assessment of Disease Activity with MR Angiography Using an Intravascular Contrast Media (Gadofosveset) in Takayasu’s Arteritis

1235

Cardiovascular Outcomes in Giant Cell Arteritis

1236

Noninfectious Ascending Aortitis: A Clinicopathologic Review of 64 Cases

1237

Primary Central Nervous System Vasculitis with Spinal Cord Involvement

1238

Primary Central Nervous System Vasculitis: Comparison of Patients with and without Cerebral Amyloid Angiopathy

1239

A High Frequency of Carotid Artery Involvement in Takayasu Detected by Intima Medial Thickness

1240

Features of Temporal Artery Biopsy and Diagnostic of Giant Cell Arteritis: The Multicentric, Prospective GRACG Study

1241

Evaluation of Long-Term Remissions after Treatment with Interferon-alfa2a for Ocular Behcet`s Disease

1242

Cause of Death in Patients with Hepatitis C (HCV)-Mixed Cryoglobulinemia (MC) Vasculitis

1243

NKG₂D Stimulated T Cell Autoreactivity in Polymyalgia Rheumatica and Giant Cell Arteritis

1244

Epidemiology of Behçet’s Disease (BD) in a Multiethnic French Population

1245

CD24 A57V Genetic Variant Confers Susceptibility to Giant Cell Arteritis

1246

Clinical Manifestations and Ethnic Background of Patients with Behcet’s Syndrome in a US Cohort

1247

Treatment of Venous Thrombosis Associated with Behcet’s Disease: Immunosuppressive Therapy Alone Versus Immunosuppressive Therapy Plus Anticoagulation

1248

The Long Term Prognosis of Behçet’s Syndrome among Men with Skin-Mucosa Involvement at Onset: Re-Evaluation of a Cohort of Patients Enrolled in a Controlled Trial

1249

Treatment of Rheumatoid Vasculitis with Rituximab : Data from the French Registry Air (Autoimmunity and Rituximab)

1250

Gender Predicts Prolonged Corticosteroid Use in Giant Cell Arteritis (GCA)

See more of: ACR Abstract Submission Poster Sessions

<< Previous Session Level | Next Session Level >>